Literature DB >> 14722287

Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.

Yoshiyuki Yokomaku1, Hideka Miura, Hiroko Tomiyama, Ai Kawana-Tachikawa, Masafumi Takiguchi, Asato Kojima, Yoshiyuki Nagai, Aikichi Iwamoto, Zene Matsuda, Koya Ariyoshi.   

Abstract

Investigating escape mechanisms of human immunodeficiency virus type 1 (HIV-1) from cytotoxic T lymphocytes (CTLs) is essential for understanding the pathogenesis of HIV-1 infection and developing effective vaccines. To study the processing and presentation of known CTL epitopes, we prepared Epstein-Barr virus-transformed B cells that endogenously express the gag gene of six field isolates by adopting an env/nef-deletion HIV-1 vector pseudotyped with vesicular stomatitis virus G protein and then tested them for the recognition by Gag epitope-specific CTL lines or clones. We observed that two field variants, SLFNTVAVL and SVYNTVATL, of an A*0201-restricted Gag CTL epitope SLYNTVATL, and three field variants, KYRLKHLVW, QYRLKHIVW, and RYRLKHLVW, of an A24-restricted Gag CTL epitope KYKLKHIVW escaped from being killed by the CTL lines, despite the fact that they were recognized when the synthetic peptides corresponding to these variant sequences were exogenously loaded onto the target cells. Thus, their escape is likely due to the changes that occur during the processing and presentation of epitopes in the infected cells. Mutations responsible for this mode of escape were located within the epitope regions rather than the flanking regions, and such mutations did not influence the virus replication. The results suggest that the impaired antigen processing and presentation often occur in HIV-1 field isolates and thus are one of the major mechanisms that enable HIV-1 to escape from CTL recognition. We emphasize the importance of testing HIV-1 variants in an endogenous expression system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722287      PMCID: PMC321367          DOI: 10.1128/jvi.78.3.1324-1332.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Degradation of cell proteins and the generation of MHC class I-presented peptides.

Authors:  K L Rock; A L Goldberg
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 2.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

3.  Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules.

Authors:  H Tomiyama; T Sakaguchi; K Miwa; S Oka; A Iwamoto; Y Kaneko; M Takiguchi
Journal:  Hum Immunol       Date:  1999-03       Impact factor: 2.850

4.  Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope derived from HIV-1 Gag protein.

Authors:  Y Ikeda-Moore; H Tomiyama; M Ibe; S Oka; K Miwa; Y Kaneko; M Takiguchi
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

5.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.

Authors:  P J Goulder; R E Phillips; R A Colbert; S McAdam; G Ogg; M A Nowak; P Giangrande; G Luzzi; B Morgan; A Edwards; A J McMichael; S Rowland-Jones
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

6.  A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.

Authors:  F Ossendorp; M Eggers; A Neisig; T Ruppert; M Groettrup; A Sijts; E Mengedë; P M Kloetzel; J Neefjes; U Koszinowski; C Melief
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

7.  Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

Authors:  O O Yang; S A Kalams; A Trocha; H Cao; A Luster; R P Johnson; B D Walker
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

9.  Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.

Authors:  C A Van Baalen; M Schutten; R C Huisman; P H Boers; R A Gruters; A D Osterhaus
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.

Authors:  T Kerkau; I Bacik; J R Bennink; J W Yewdell; T Húnig; A Schimpl; U Schubert
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  64 in total

1.  Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.

Authors:  Tomohiro Akahoshi; Takayuki Chikata; Yoshiko Tamura; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.

Authors:  Hirokazu Koizumi; Masao Hashimoto; Mamoru Fujiwara; Hayato Murakoshi; Takayuki Chikata; Mohamed Ali Borghan; Atsuko Hachiya; Yuka Kawashima; Hiroshi Takata; Takamasa Ueno; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Selection on the human immunodeficiency virus type 1 proteome following primary infection.

Authors:  Yi Liu; John McNevin; Jianhong Cao; Hong Zhao; Indira Genowati; Kim Wong; Sherry McLaughlin; Matthew D McSweyn; Kurt Diem; Claire E Stevens; Janine Maenza; Hongxia He; David C Nickle; Daniel Shriner; Sarah E Holte; Ann C Collier; Lawrence Corey; M Juliana McElrath; James I Mullins
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

Authors:  Biswanath Majumder; Michelle L Janket; Elizabeth A Schafer; Keri Schaubert; Xiao-Li Huang; June Kan-Mitchell; Charles R Rinaldo; Velpandi Ayyavoo
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences.

Authors:  Laura E Valentine; Shari M Piaskowski; Eva G Rakasz; Nathan L Henry; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

6.  High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.

Authors:  Alleluiah Rutebemberwa; Stuart C Ray; Jacquie Astemborski; Jordana Levine; Lin Liu; Kimberly A Dowd; Shalyn Clute; Changyu Wang; Alan Korman; Alessandro Sette; John Sidney; Drew M Pardoll; Andrea L Cox
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  Partial escape of HIV-1 from cytotoxic T lymphocytes during chronic infection.

Authors:  Martha J Lewis; Mirabelle Dagarag; Basim Khan; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

8.  Viral CD8 T cell epitope nucleotide composition shows evidence of short- and long-term evolutionary strategies.

Authors:  Yaakov Maman; Uri Hershberg; Yoram Louzoun
Journal:  Immunogenetics       Date:  2014-11-08       Impact factor: 2.846

9.  Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level.

Authors:  Golo Ahlenstiel; Kirsten Roomp; Martin Däumer; Jacob Nattermann; Martin Vogel; Jürgen K Rockstroh; Niko Beerenwinkel; Rolf Kaiser; Hans-Dieter Nischalke; Tilman Sauerbruch; Thomas Lengauer; Ulrich Spengler
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

10.  Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.

Authors:  Mamoru Fujiwara; Junko Tanuma; Hirokazu Koizumi; Yuka Kawashima; Kazutaka Honda; Saori Mastuoka-Aizawa; Sachi Dohki; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.